<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AIMS: Mesenchymal stromal cells (MSC) have been shown to be a promising candidate for tissue regeneration and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> therapy </plain></SENT>
<SENT sid="1" pm="."><plain>However, their therapeutic potential against chemotherapy-induced side-effects remains unclear </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We treated murine Lewis <z:mp ids='MP_0008714'>lung carcinoma</z:mp> (LLC) and xenograft human <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumors</z:e> with adriamycin (ADM) for 3 consecutive days followed by one intravenous (i.v.) injection of human umbilical cord (hUC) MSC for several cycles </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: MSC treatment mitigated ADM-induced <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>, reduced the extent of ADM-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in intestinal crypts, suppressed body <z:hpo ids='HP_0001824'>weight loss</z:hpo> in mice treated with ADM and increased the survival rate of mice treated with a lethal dose of ADM </plain></SENT>
<SENT sid="4" pm="."><plain>The examination of hematologic parameters indicated a moderate recovery in MSC-injected mice </plain></SENT>
<SENT sid="5" pm="."><plain>Systemic administration of MSC did not increase the growth of murine LLC cells and human colon <z:mp ids='MP_0002038'>carcinoma</z:mp> in vivo while it strongly inhibited the <z:e sem="disease" ids="C0153676" disease_type="Neoplastic Process" abbrv="">lung metastases</z:e> of LLC cells </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: We evaluated the prophylactic and therapeutic action of hUC MSC on the chemotherapy agent ADM-induced side-effects in two different <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> models </plain></SENT>
<SENT sid="7" pm="."><plain>Our observations suggest that MSC can be used as auxiliary means in chemotherapy for certain <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> types </plain></SENT>
</text></document>